Several newer retrospective studies, however, failed to show any association between chemotherapy and outcome in pT1abN0 TNBC tumours [16, 18, 19], emphasizing the need for prospective trials on this group of patients, receiving modern locoregional therapy and using relevant definitions of hormone receptor status and HER2-status. The gene discussed is NR4A1; the disease is neoplasm.